HSCA Announces 2019 Board of Directors and Names GNYHA Ventures President Lee Perlman Board Chair
Washington, DC (January, 2019) – The Healthcare Supply Chain Association (HSCA) today announced that GNYHA Ventures, Inc. President Lee Perlman will serve as Chair of HSCA’s Board of Directors, replacing HealthTrust CEO Ed Jones, who will serve as Immediate Past Chair. GNYHA Ventures, the business arm of Greater New York Hospital Association, includes the group purchasing organization Acurity,...
Learn MoreComments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Food and Drug Administration (FDA) on the causes of critical prescription drug shortages and potential solutions.
HSCA, its member GPOs, and our member healthcare providers are committed to preventing and mitigating prescription drug shortages and ensuring continued...
Learn MoreHSCA Statement on Senate HELP Committee Hearing on Reducing Costs through Innovation
Washington, DC (November 28, 2018) – Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph., today released the following statement in conjunction with “Reducing Health Care Costs: Improving Affordability Through Innovation,” a hearing before the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP):
“The Healthcare Supply Chain Association applauds...
Learn MoreComments of the Healthcare Supply Chain Association (HSCA) to FDA on Facilitating Competition and Innovation in the Biological Products Marketplace
On behalf of the Healthcare Supply Chain Association (HSCA), thank you for the opportunity to provide comments on the U.S. Food and Drug Administration’s (FDA) “Facilitating Competition and Innovation in the Biological Products Marketplace.”
The ability to safely substitute FDA-approved biosimilars for reference biologics will be critical to realizing the full cost-savings potential of...
Learn MoreHSCA Comments on DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments on the U.S. Drug Enforcement Administration’s (DEA) proposed aggregate production quotas for Schedule I and II controlled substances.
HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs), the sourcing and purchasing partners to virtually all of...
Learn MoreHSCA Releases Second Annual Report on Value GPOs Deliver to the Healthcare Supply Chain
Washington, DC (August 21, 2018) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today released its second annual report on the value that GPOs deliver to the healthcare system. The report, which was based on a survey of HSCA member GPOs, found that GPOs continue to deliver critical cost savings to...
Learn MoreComments of the Healthcare Supply Chain Association on the Department of Health and Human Services Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the Department of Health and Human Services (HHS) on the “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.” HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs), the sourcing and purchasing partners to virtually all of America’s 7,000+...
Learn More